Showing the single result

Breast Tissue Markers Market Analysis | United States | 2016-2022 | MedCore

The value of the U.S. breast tissue marker market is expected to increase modestly over the forecast period. Growth in the value of the market will be driven by increasing unit sales and limited by ASP erosion. The increasing incidence of breast cancer and utilization of breast tissue markers in percutaneous breast biopsies as well as axillary lymph node marking are expected to fuel unit sales growth over the next seven years. ASP erosion will be driven by commoditization of breast tissue markers with lower clinical value.